Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_assertion type Assertion NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_head.
- NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_assertion description "[MET, a receptor tyrosine kinase for hepatocyte growth factor, is associated with tumor progression and acquired resistance to epidermal growth factor tyrosine kinase inhibitors (EGFR-TKI).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.
- NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_assertion evidence source_evidence_literature NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.
- NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_assertion SIO_000772 21733594 NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.
- NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_assertion wasDerivedFrom befree-20150227 NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.
- NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_assertion wasGeneratedBy ECO_0000203 NP802979.RAm-I2-fTAjEnfdcAa7-LpNPMiIVJHgX1rqMq5l1BqtOk130_provenance.